These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Improving lysine production through construction of an Escherichia coli enzyme-constrained model. Ye C; Luo Q; Guo L; Gao C; Xu N; Zhang L; Liu L; Chen X Biotechnol Bioeng; 2020 Nov; 117(11):3533-3544. PubMed ID: 32648933 [TBL] [Abstract][Full Text] [Related]
9. Van Raad D; Huber T ACS Synth Biol; 2021 May; 10(5):1237-1244. PubMed ID: 33969993 [TBL] [Abstract][Full Text] [Related]
11. Cell-Free Protein Synthesis for High-Throughput Biosynthetic Pathway Prototyping. Rasor BJ; Vögeli B; Jewett MC; Karim AS Methods Mol Biol; 2022; 2433():199-215. PubMed ID: 34985746 [TBL] [Abstract][Full Text] [Related]
12. Holistic engineering of cell-free systems through proteome-reprogramming synthetic circuits. Contreras-Llano LE; Meyer C; Liu Y; Sarker M; Lim S; Longo ML; Tan C Nat Commun; 2020 Jun; 11(1):3138. PubMed ID: 32561745 [TBL] [Abstract][Full Text] [Related]
13. Engineering E. coli for caffeic acid biosynthesis from renewable sugars. Zhang H; Stephanopoulos G Appl Microbiol Biotechnol; 2013 Apr; 97(8):3333-41. PubMed ID: 23179615 [TBL] [Abstract][Full Text] [Related]
14. In vitro prototyping and rapid optimization of biosynthetic enzymes for cell design. Karim AS; Dudley QM; Juminaga A; Yuan Y; Crowe SA; Heggestad JT; Garg S; Abdalla T; Grubbe WS; Rasor BJ; Coar DN; Torculas M; Krein M; Liew FE; Quattlebaum A; Jensen RO; Stuart JA; Simpson SD; Köpke M; Jewett MC Nat Chem Biol; 2020 Aug; 16(8):912-919. PubMed ID: 32541965 [TBL] [Abstract][Full Text] [Related]
15. De novo biosynthesis of pterostilbene in an Escherichia coli strain using a new resveratrol O-methyltransferase from Arabidopsis. Heo KT; Kang SY; Hong YS Microb Cell Fact; 2017 Feb; 16(1):30. PubMed ID: 28202018 [TBL] [Abstract][Full Text] [Related]
16. Metabolic engineering of isopropyl alcohol-producing Escherichia coli strains with Okahashi N; Matsuda F; Yoshikawa K; Shirai T; Matsumoto Y; Wada M; Shimizu H Biotechnol Bioeng; 2017 Dec; 114(12):2782-2793. PubMed ID: 28755490 [TBL] [Abstract][Full Text] [Related]
17. Engineering and comparison of non-natural pathways for microbial phenol production. Thompson B; Machas M; Nielsen DR Biotechnol Bioeng; 2016 Aug; 113(8):1745-54. PubMed ID: 26804162 [TBL] [Abstract][Full Text] [Related]
18. Metabolic engineering of Corynebacterium glutamicum for shikimate overproduction by growth-arrested cell reaction. Kogure T; Kubota T; Suda M; Hiraga K; Inui M Metab Eng; 2016 Nov; 38():204-216. PubMed ID: 27553883 [TBL] [Abstract][Full Text] [Related]
19. Metabolic engineering of Escherichia coli for improving shikimate synthesis from glucose. Chen X; Li M; Zhou L; Shen W; Algasan G; Fan Y; Wang Z Bioresour Technol; 2014 Aug; 166():64-71. PubMed ID: 24905044 [TBL] [Abstract][Full Text] [Related]
20. Expanding metabolic pathway for de novo biosynthesis of the chiral pharmaceutical intermediate L-pipecolic acid in Escherichia coli. Ying H; Tao S; Wang J; Ma W; Chen K; Wang X; Ouyang P Microb Cell Fact; 2017 Mar; 16(1):52. PubMed ID: 28347340 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]